Bruce Roth

Bruce Roth Email and Phone Number

Senior Scientist II at Inzen Therapeutics @ Alkermes
Bruce Roth's Location
Tyngsborough, Massachusetts, United States, United States
Bruce Roth's Contact Details

Bruce Roth personal email

n/a
About Bruce Roth

Resourceful research-oriented cell biologist with extensive experience in assay development, particularly fluorescence techniques utilizing imaging microscopy (high-content, epi-fluorescence, confocal, deconvolution), flow cytometry, fluorometry, fluorescence spectroscopy, and microplate readers related to bacteria, yeast, and mammalian cell usage. A highly motivated individual with many years of hands-on tissue culture experience: primary cell isolation and propagation, protein overexpression and knockdown utilizing transfections and retroviral transduction (stable and transient), stable clone isolation/characterization. Protein overexpression/knockdown was assessed using Western blotting, ELISA, High Content Imaging, flow cytometry, and microplate readers. A proven track record in development of new reagents, techniques, and instrumentation for a wide range of biological research applications. Next generation sequencing DNA/RNA bulk, single cell and single nuclei with epigenetic characterization V(D)J , TCR/BCR and CITESeq. Specialties: High content imaging and quantitative analysisFlow cytometryCellular assay development (proliferation, cytotoxicity, apoptosis, and reporter gene assays)Tissue culture: primary cell isolation, characterization, and propagation (creation, passage, cataloging, long-term cryopreservation, expansion to large flask/roller bottles, and dose preparation for xenograft/allograft modeling)

Bruce Roth's Current Company Details
Alkermes

Alkermes

View
Senior Scientist II at Inzen Therapeutics
Bruce Roth Work Experience Details
  • Inzen Therapeutics
    Senior Scientist Ii
    Inzen Therapeutics Jan 2022 - Present
  • Alkermes
    Senior Scientist
    Alkermes Sep 2017 - Present
    Dublin, Ie
  • Alkermes
    Associate Principal Scientist
    Alkermes Mar 2021 - Feb 2022
    Dublin, Ie
    An active member of the In Vitro Disease Modeling (IVDM) Group. Provide immune-oncology and neurobiology project teams with disease and drug mechanism of action (MOA) information through the use of gene expression and functional genomic analysis using a variety of Next Generation Sequencing (NGS) and other methods. Perform bulk RNA/DNA sequencing in-house utilizing the ThermoFisher Ion GeneStudio S5 Prime System. Perform single cell RNAseq including V(D)J TCR/BCR, and CITESeq using the 10X Genomic’s platform to generate libraries in-house while outsourcing the sequencing. Samples range from cell lines, blood, excised tissues, tumors, spheroids, and iPSC derived organoids.
  • Institute For Applied Cancer Science Neurodegeneration Consortium Iacs-Ndc Md Anderson Cancer Center
    Institute Research Investigator - Target Biology Neuroscience
    Institute For Applied Cancer Science Neurodegeneration Consortium Iacs-Ndc Md Anderson Cancer Center Aug 2015 - Sep 2017
    Houston, Tx, Us
    Participate in cross-functional research to identify and validate novel neurodegeneration targets related to Alzheimer's disease, and translate the findings into novel neurodegeneration therapeutic agents to benefit patients.
  • Vertex Pharmaceuticals
    Sr. Research Scientist
    Vertex Pharmaceuticals Feb 2015 - Aug 2015
    Boston, Ma, Us
  • Vertex Pharmaceuticals
    Research Scientist Ii
    Vertex Pharmaceuticals Sep 2011 - Jan 2015
    Boston, Ma, Us
    Design and implementation of image based phenotypic small molecule library screens in the neurobiology arena.Screen for small molecule inhibitors of axonal (Wallerian) degenerationDeveloped a high throughput 384 well, label-free, image based assay utilizing dissociated rat dorsal root ganglion (DRG) neurons. Vincristine, a microtubule destabilizer, was used as a chemical injury agent to screen small molecule libraries for inhibitors of axonal degeneration. Responsible for cross-site transfer of the assay and cross-site management of the screen at our Vertex San Diego facility. Developed a low-medium throughput 96 well axotomy (severed axon injury) assay as a confirmatory assay for the original library screen hits and to find compounds which protect under both injury conditions. Active participant in Axon Protection pre-project team with med-chem support; selection of lead compounds and follow-up compound SAR.Screen for small molecules that induce oligodendrocyte differentiation and/or enhance myelin/myelinationImplemented 96 and 384 well, image based screens utilizing P1 rat mixed primary cortical cultures. Hits from the initial screen are further assessed for their ability to myelinate the neurons in longer duration P1 rat mixed primary cortical cultures.
  • Myrexis, Inc. (Formerly Myriad Pharmaceuticals, Inc.)
    Scientist I
    Myrexis, Inc. (Formerly Myriad Pharmaceuticals, Inc.) Apr 2002 - 2011
    Salt Lake City, Utah, Us
    I worked as part of a small imaging core group utilizing The BD Pathway imaging system capable of both standard fluorescence and confocal imaging. My responsibilities include developing low to medium throughput 96 well imaging assays that demonstrate small molecule target specific responses (Mechanism Based Cellular Assays, MBCA), and generating dose response curves. The imaging assays I have designed to date are a mix of live and fixed cell utilizing both standard and confocal imaging techniques.
  • Myriad Pharmaceuticals Inc.
    Research Associate Iv
    Myriad Pharmaceuticals Inc. Apr 2002 - Jun 2004
  • Lexicon Pharmaceuticals (Formerly Lexicon Genetics Inc.)
    Senior Research Associate
    Lexicon Pharmaceuticals (Formerly Lexicon Genetics Inc.) 2001 - 2002
    The Woodlands, Tx, Us
  • Arcaris (Formerly Ventana Genetics, Inc.)
    Research Assistant Iv/Flow Cytometry Core Manager
    Arcaris (Formerly Ventana Genetics, Inc.) 1998 - 2001
  • Molecular Probes, Inc
    Scientist I
    Molecular Probes, Inc 1991 - 1998
  • Cell Systems Corporation
    Tissue Culture Production Lab Manager
    Cell Systems Corporation 1990 - 1991
  • Bio Techniques Laboratories, Inc.
    Research Associate I
    Bio Techniques Laboratories, Inc. 1988 - 1990

Bruce Roth Skills

Cell Flow Cytometry Transfection Assay Development Tissue Culture Elisa Protein Chemistry Fluorescence Western Blotting Microscopy Confocal Microscopy Laboratory Fluorescence Spectroscopy Drug Discovery Apoptosis In Vitro Cell Culture Immunoassays Rna Isolation Biotechnology Life Sciences

Bruce Roth Education Details

  • Oregon State University
    Oregon State University
    Microbiology

Frequently Asked Questions about Bruce Roth

What company does Bruce Roth work for?

Bruce Roth works for Alkermes

What is Bruce Roth's role at the current company?

Bruce Roth's current role is Senior Scientist II at Inzen Therapeutics.

What is Bruce Roth's email address?

Bruce Roth's email address is br****@****rma.com

What schools did Bruce Roth attend?

Bruce Roth attended Oregon State University.

What skills is Bruce Roth known for?

Bruce Roth has skills like Cell, Flow Cytometry, Transfection, Assay Development, Tissue Culture, Elisa, Protein Chemistry, Fluorescence, Western Blotting, Microscopy, Confocal Microscopy, Laboratory.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.